News

Corbus Pharmaceuticals Welcomes Rachelle Jacques as New Board Chair

Corbus Pharmaceuticals Welcomes Rachelle Jacques as New Board Chair

Corbus Pharmaceuticals Welcomes Rachelle Jacques as New Board Chair

Norwood, Massachusetts — Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a prominent clinical-stage biopharmaceutical company dedicated to tackling oncology and obesity, has appointed Rachelle Jacques as Chair of its Board of Directors. This change became effective on May 15, marking a significant shift in leadership as she takes the reins from the founding Chair, Alan Holmer, who will continue to serve on the Board.

Yuval Cohen, Ph.D., the Chief Executive Officer of Corbus, expressed gratitude towards Alan Holmer for his over ten years of dedicated leadership. "Rachelle is a seasoned biopharmaceutical executive, and her innovative and strategic thinking has been invaluable to us as a Board member. We anticipate her vision and leadership as we embark on an exciting new chapter, with pivotal clinical readouts from our pipeline expected soon," he stated.

Rachelle Jacques: Experience and Vision

Rachelle Jacques shared her enthusiasm about stepping into the Chair role at a critical time for Corbus. "I feel privileged to take on this responsibility as we push our diverse pipeline towards significant milestones this year," she remarked. Jacques highlighted the company’s targeted oncology programs, CRB-701 and CRB-601, which aim to combat aggressive cancers. Additionally, she noted their obesity program, designed to address a pressing public health challenge, as a driving force for her motivation.

Reflecting on his tenure, Alan Holmer remarked, "Serving as Chair has been both an honor and privilege. We are clearly on a positive and exciting trajectory. Rachelle's extensive background in both big pharma and biotech will be crucial as we navigate this transition smoothly together." Jacques’ years of service on Corbus' Board and her contributions to various committees have led to this significant advancement in her career.

Jacques’ Background and Achievements

With over 25 years of experience in leadership, Rachelle Jacques has a proven track record of driving transformative therapies through various roles, including CEO and other high-ranking executive positions. She has been instrumental in advancing key initiatives at Corbus Pharmaceuticals and has previously served on the board of directors of uniQure N.V. (Nasdaq: QURE), accelerating gene therapies for genetic diseases. Her leadership journey included being the CEO of Akari Therapeutics Plc (Nasdaq: AKTX), where she developed treatments for autoimmune and inflammatory diseases.

Jacques has also held notable roles such as senior vice president at Alexion Pharmaceuticals, where she directed global commercialization strategies across multiple therapeutic areas. Her early career featured positions at Baxter, encompassing business operations and finance, and she has extensive international experience from her time at Dow Corning, managing operations across several continents.

Corbus’ Commitment to Innovation

Corbus Pharmaceuticals is committed to innovating solutions to tackle serious health challenges. The company’s therapeutic pipeline includes CRB-701, an advanced antibody-drug conjugate targeting cancer cells; CRB-601, an anti-integrin monoclonal antibody aimed at inhibiting TGF? activation; and CRB-913, which acts as a CB1 receptor inverse agonist designed for obesity treatment. This ambitious pipeline reflects the company's resolve in addressing critical health care issues.

As Corbus progresses, its headquarters located in Norwood remains the hub for navigating these advancements. The company is dedicated to exploring and developing scientifically-backed therapies that not only meet the immediate needs of patients but also pave the way for future innovations.

Through a combination of pioneering research, strategic leadership, and a clear vision for the future, Corbus Pharmaceuticals is poised to create meaningful change in the biopharmaceutical landscape.

Frequently Asked Questions

What does Rachelle Jacques’ appointment as Board Chair signify for Corbus?

Her appointment represents a commitment to strong leadership and strategic direction as the company advances its innovative pipeline of treatments.

How long has Rachelle Jacques been with Corbus Pharmaceuticals?

Rachelle Jacques has been a member of the Corbus Pharmaceuticals Board for over six years before becoming Chair.

What are the primary goals of Corbus Pharmaceuticals?

Corbus aims to develop therapies that address serious health conditions, particularly in oncology and obesity, through innovative scientific approaches.

What role did Alan Holmer play in Corbus Pharmaceuticals?

Alan Holmer served as the founding Chair of the Board and has provided leadership over the past ten years, continuing to support the company as a Board member.

Where is Corbus Pharmaceuticals headquartered?

The company is headquartered in Norwood, Massachusetts, and focuses on developing advanced therapeutic solutions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

NVE Revenue Pull-Forward Raises Hard Investor Questions

Updated Category News Views 110

A Quarter Can Look Great Until It Doesn’t NVE investors got a nasty lesson in revenue timing, the sort that makes even old hands check the fine print twice. On July 22, 2026, the company reported sequential revenue growth of 43% and net-income growth of 23%. The next trading day, shares vaulted $47.53, or 54%. Then came October, and the floor gave way: NVE reported that...

Continue Reading
Holland America Puts 2028 Alaska Demand on Display

Updated Category News Views 123

Alaska’s interior is where a cruise brochure either earns its keep or gets exposed. Holland America Line is opening bookings for 2028 Alaska Cruisetours nearly two years ahead, tying a coast-and-land product to the reimagined Oosterdam’s Alaska debut. That is not merely another itinerary release. It is a fairly deliberate attempt to sell a bigger, longer and...

Continue Reading
NYSE Message Record Puts Market Plumbing Into Focus

Updated Category News Views 120

A trillion messages is not a cute little exchange statistic; it is the sort of number that tells you whether the market’s pipes can keep working when everybody starts shouting at once. NYSE says it handled a record 1.166 trillion messages in one day on November 5, roughly 4% above the prior high set amid April 2025 volatility. Better yet, according to the exchange,...

Continue Reading
Yiwu Squishies Turn Viral Demand Into Factory Backlogs Worldwide

Updated Category News Views 87

A pizza-shaped stress toy booking more than one million units is the sort of detail that makes a jaded market watcher sit up before rolling his eyes at the word “viral.” Yiwu’s squishy-toy surge appears to have moved beyond a few social-media impulses and into actual factory scheduling, repeat purchase orders and supermarket procurement. That is meaningful. It is...

Continue Reading
Five Films Put Modern Infrastructure Under a Lens

Updated Category News Views 121

Most infrastructure only earns a thought when it breaks, and that is precisely the nerve these films are trying to touch. Nicely Done Productions has released the final five installments of its ten-part Threads of Connectivity documentary series, hosted on National Geographic's global digital platform. The subjects are illycaffè, Cargill, Honeywell Aerospace, Western...

Continue Reading
Africa’s Digital Leap Still Has a 64% Usage Problem

Updated Category News Views 100

A continent can be blanketed in signal and still feel digitally stranded. That is the stubborn fact sitting inside the GSMA Digital Africa Index 2026: mobile broadband reaches 92% of Africa’s population, while only 28% use mobile internet on their own devices. The 64% usage gap is not a rounding error or a tidy policy footnote. It is the whole unfinished job. From an...

Continue Reading
MFB Bancorp Offering Puts Chicago Bank Conversion First

Updated Category News Views 70

A small Chicago thrift is asking investors to fund a corporate makeover, and the fine print matters more than the $10 sticker price. MFB Bancorp has commenced an offering tied to the planned conversion of Mutual Federal Bancorp, MHC from a mutual holding company structure into a stock holding company. This is not some high-growth bank story with a shiny new branch map. It...

Continue Reading
StoneX Selloff Puts Earnings Quality Under a Harsh Lens

Updated Category News Views 111

A revenue beat can turn downright useless when the profit line springs a leak. StoneX Group delivered operating revenue above expectations and record full-year results, then watched investors hammer the stock after fiscal fourth-quarter diluted earnings per share landed at $0.66. That was $0.15 below the roughly $0.81 consensus cited in the notice, and other estimates...

Continue Reading
IDEMIA Lands Sweden's Critical 5G Connectivity Job

Updated Category News Views 108

A hospital monitor going dark because a device was misprovisioned is not the kind of connectivity hiccup anybody gets to shrug off. That is why IDEMIA Secure Transactions winning the Region Västra Götaland assignment deserves more attention than the usual telecom plumbing announcement. The region is building what it calls Sweden's largest private 5G network, and the job...

Continue Reading
Securitize Tests the IPO Clock With Anthropic Tokens

Updated Category News Views 93

Anthropic did not even get a full trading day to itself before the tokenization crowd arrived. Securitize says Anthropic stock became available through Securitize Stocks on Solana on the company’s first day as a public company, a loud little signal that the old IPO playbook is being prodded from the edges. For investors, this is not merely another crypto-flavored...

Continue Reading

Top 5 Most Recently Viewed Articles

McDonald's Earnings Anticipation: Insights from Analysts Ahead

Updated Category News Views 110

Anticipating McDonald's Q3 Earnings Report As the third quarter approaches, McDonald's Corporation (NYSE: MCD) is preparing to unveil its earnings report, sparking interest among investors and analysts alike. This significant event is anticipated to occur just before the opening bell, offering crucial insights into the company's financial health and market position. What...

Continue Reading
BC Platforms Unveils Game-Changing AI Technology for Researchers

Updated Category News Views 281

BC Platforms Introduces BC Catalyst for Precision Medicine BC Platforms has officially launched BC Catalyst, an innovative AI-native analytics product designed to enhance precision medicine. This breakthrough technology integrates genomic and real-world data, allowing for actionable insights throughout the entire drug lifecycle. With BC Catalyst, the company aims to...

Continue Reading
TestFly Expands QA Testing Services with Red Cerberus Deal

Updated Category News Views 300

TestFly Enhances Service Offerings Through Acquisition TestFly, a prominent provider of innovative quality assurance testing solutions for the video game and mobile gaming sectors, has undertaken a significant move by acquiring Red Cerberus. This acquisition is set to transform the landscape of video game quality assurance by integrating Red Cerberus' expertise and...

Continue Reading
Unveiling Insurance Industry Abuses: New Podcast Series Launch

Updated Category News Views 173

Consumer Watchdog Introduces Insightful Podcast Series Smoke & Mirrors Debuts Today, Investigating Insurance Underpayments and Consumer Resilience Today marks the launch of a groundbreaking podcast series from Consumer Watchdog, titled "Smoke & Mirrors: Investigating Home Insurance Abuses," aimed at shedding light on the troubling practices that major insurance firms...

Continue Reading
MongoDB’s Leadership Change: Opportunities for Investors Ahead

Updated Category News Views 171

Understanding the Leadership Shift at MongoDB Recently, MongoDB (NASDAQ: MDB) has been a significant topic of discussion in investing circles due to its remarkable stock performance. After the stock's impressive rise from $188.81 to about $358 per share, many are questioning the right strategy—should investors lock in their profits now or remain committed for the long...

Continue Reading